Covid survivor scores 79.83% in HSC, highest among night school students in Vidarbha
Three years ago, Shahnaz Pathan lay on a ventilator, fighting for her life during the second wave of Covid-19. This week, the 37-year-old mother of two and a student of Commerce at Shri Shivaji Night High School and Junior College, Nagpur scored 79.83% in her Class 12 board exams, one of the highest among night school students in Vidarbha.
During the second wave of Covid-19, Shahnaz Pathan spent 22 days on a ventilator at Pune 's Auto Cluster Covid Hospital. Doctors had nearly given up hope. But a resilient Shahnaz recovered.
The pandemic also cost her a job, prompting a move to Pune in 2020. With an ITI diploma, she secured a sales role at a European firm. But she knew a degree was essential to grow in the field.
A mother of two, Shahnaz enrolled in Nagpur's Shri Shivaji Night High School and Junior College. Each month, she travelled from Pune to attend classes, balancing her job with studies and extra coaching.
On May 5, when Maharashtra's Class 12 results were announced, she scored 79.83% in
Commerce, the highest among night school students in Vidarbha. 'I dropped out after Class 10 due to financial issues. Now I want to complete my graduation and even pursue an MBA,' she says.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
3 hours ago
- Business Standard
10 Covid deaths reported in India in 24 hours, active cases drop to 7,383
Of the ten reported fatalities, three were from Delhi, five from Kerala, and two from Maharashtra Vrinda Goel New Delhi India's active Covid-19 caseload declined slightly to 7,383 on Sunday, down from 7,400 the previous day, with 17 new infections and 10 fatalities reported in the past 24 hours, according to the Ministry of Health and Family Welfare. Of the ten reported fatalities, three were from Delhi, five from Kerala, and two from Maharashtra. Among the deceased was a 32-year-old man from Maharashtra, while the remaining nine were elderly individuals with pre-existing respiratory issues and chronic health conditions. New subvariants drive surge India is currently witnessing a rise in Covid-19 cases, attributed to emerging subvariants including LF.7, XFG, JN.1, and the recently identified NB.1.8.1. State-wise update: Kerala tops active cases Kerala saw the largest single-day drop, with 102 fewer cases in the past 24 hours, while Maharashtra recorded a decline of 35. In contrast, Delhi reported an increase of 10 active cases during the same period. Experts advise targeted boosters Health experts have recommended against launching a mass booster vaccination drive in response to the current rise in infections. Instead, they have suggested a targeted strategy focusing on high-risk populations, including the elderly, immunocompromised individuals, and those with chronic conditions. Emphasis on precautions and early care Experts continue to emphasise the importance of Covid-appropriate behaviour, such as wearing masks, maintaining hand hygiene, and avoiding crowded places. Amid the rising infection numbers, the central government has issued advisories to states and union territories, urging increased vigilance and readiness. Healthcare professionals have also highlighted the need to differentiate between Covid-19 and other seasonal viral infections, which often present with similar symptoms such as fever, fatigue, and respiratory distress. The Indian Medical Association has reiterated the importance of preventive measures, including masking and adherence to hygiene practices, to contain the spread of the virus.
&w=3840&q=100)
Business Standard
3 hours ago
- Business Standard
Anti-infective drug sales surge in May as fever season grips country
Analysts indicate sales in the segment are expected to grow more during monsoon months premium Sanket Koul New Delhi Listen to This Article Sales of anti-infective drugs in India grew 7.6 per cent year-on-year (Y-o-Y) to ₹2,130 crore in May 2025, up from ₹1,979 crore in the same month last year, driven by the onset of the viral season and a rise in Covid-19 cases, according to analysts and medical experts. Within the anti-infective segment—which accounts for about 11 per cent of total Indian Pharma Market (IPM) revenue—sub-groups such as antibacterials and antifungals led growth, with sales rising 9.1 per cent and 7 per cent, respectively, in May. Data from market research firm Pharmarack shows antibacterial sales increased from ₹1,676 crore in May
United News of India
4 hours ago
- United News of India
India reports 10 more Covid-19 deaths amid slight in active cases
New Delhi, June 15 (UNI) The total number of active Covid-19 cases in India dropped slightly to 7,383 on Sunday, down by 17 cases from 7,400 a day earlier, according to the latest data released by the Union Health Ministry at 8 am. However, deaths due to Covid pathogen cases increased by 10 to 97, the Ministry said. Three deaths were reported in Delhi, five in Kerala and two in Maharashtra. All reported cases involved individuals with significant underlying health conditions, highlighting the heightened risk posed to those with comorbidities. Fresh infections in Delhi and Madhya Pradesh increased by 10 each to touch 682 and 130 respectively, but they dropped by 102 in Kerala, though total caseload was highest among states at 2007. However, a few states including West Bengal, Arunachal Pradesh, Chandigarh, Chhattisgarh, Goa, Himachal Pradesh, Mizoram, Puducherry, and Tripura did not report any new infection, as per the government's website. The three Covid virus related deaths in Delhi included a 57-year-old woman with diabetes and chronic lung disease, a man (57) with diabetes and liver disease, and an 83-year-old woman with a medical history of diabetes, hypertension, and lung disease. In Kerala, the five deceased included an 86-year-old man with hypertension, coronary artery disease, chronic kidney disease, and dementia; a 79-year-old man with diabetes, hypertension, and kidney disease; a 70-year-old man suffering from diabetes, hypertension, and thyroid disorders; a 92-year-old woman with a history of stroke and Parkinson's disease; and a 73-year-old man with hypertension, coronary artery disease, and chronic obstructive pulmonary disease (COPD). In Maharashtra, two deaths have been confirmed. One was a 56-year-old man with diabetes and hypertension. The second was a 32-year-old man diagnosed with acute myeloid leukemia and anaemia — both conditions compromising immunity and resilience. The public health experts have urged high-risk individuals to take all recommended precautions, including masking in crowded places, and regular health checkups.
